Elanco Animal Health Inc (NYSE: ELAN) open the trading on Wednesday, with a bit cautious approach as it glided -3.54% to $22.05, before settling in for the price of $22.86 at the close. Taking a more long-term approach, ELAN posted a 52-week range of $8.02-$23.00.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 29.95%. Meanwhile, its Annual Earning per share during the time was 29.95%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 1.50%. This publicly-traded company’s shares outstanding now amounts to $496.83 million, simultaneously with a float of $492.06 million. The organization now has a market capitalization sitting at $10.96 billion. At the time of writing, stock’s 50-day Moving Average stood at $20.43, while the 200-day Moving Average is $14.68.
Elanco Animal Health Inc (ELAN) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. Elanco Animal Health Inc’s current insider ownership accounts for 0.97%, in contrast to 111.45% institutional ownership. Preceding that transaction, on Mar 07 ’25, Company’s Director bought 10,000 for 10.90, making the whole transaction’s value amount to 109,000. This particular insider is now the holder of 101,459 in total.
Elanco Animal Health Inc (ELAN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.35 per share during the current fiscal year.
Elanco Animal Health Inc’s EPS increase for this current 12-month fiscal period is 1.50% and is forecasted to reach 1.02 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.00% through the next 5 years, which can be compared against the 29.95% growth it accomplished over the previous five years trading on the market.
Elanco Animal Health Inc (NYSE: ELAN) Trading Performance Indicators
Let’s observe the current performance indicators for Elanco Animal Health Inc (ELAN). It’s Quick Ratio in the last reported quarter now stands at 1.23. Alongside those numbers, its PE Ratio stands at $302.47, and its Beta score is 1.86. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.39. Similarly, its price to free cash flow for trailing twelve months is now 29.77.
In the same vein, ELAN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.07, a figure that is expected to reach 0.12 in the next quarter, and analysts are predicting that it will be 1.02 at the market close of one year from today.
Technical Analysis of Elanco Animal Health Inc (ELAN)
[Elanco Animal Health Inc, ELAN] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 71.50% While, its Average True Range was 52.14.
Raw Stochastic average of Elanco Animal Health Inc (ELAN) in the period of the previous 100 days is set at 89.45%, which indicates a major rise in contrast to 53.98% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.78 that was higher than 0.53 volatility it exhibited in the past 100-days period.
